Related Experiment Videos
Relationship of mismatch negativity to background EEG and morphological findings in schizophrenia
1Juntendo University School of Medicine, Department of Psychiatry, Koshigaya, Saitama, Japan. kirino@biac.duke.edu
Abstract:
The present study assessed relationships of mismatch negativity (MMN) of schizophrenics with other markers; quantitative EEG (QEEG), computed tomography (CT) and psychopathological ratings. Patients were divided into two groups before treatment; group A consisted of patients with greater MMN amplitudes while patients with lower ones were assigned to group B. In QEEG, group A showed no significant differences compared to controls, except for fast beta in the frontal region. The finding of well-preserved QEEG in group A indicates their function is less distorted than in group B, who showed greater powers in slow waves, slow alpha and fast beta bands. The greater slow-wave power of group B may be related to the cognitive impairment reflected by attenuated MMN, which corresponded to greater dilation in lateral ventricles and Sylvian fissures of group B on CT. Conclusively, MMN have crucial relationships to other biological markers representing the psychopathology of schizophrenia.
Insights
Mismatch negativity (MMN) in schizophrenia correlates with other biological markers. Lower MMN amplitudes in schizophrenia patients indicate greater cognitive impairment and brain structure changes.
Area of Science:
- Neuroscience
- Psychiatry
- Biomarkers
Background:
- Schizophrenia is characterized by cognitive deficits and neurobiological alterations.
- Mismatch negativity (MMN) is an auditory event-related potential sensitive to cognitive function.
- Understanding MMN's relationship with other biomarkers can elucidate schizophrenia's pathophysiology.
Purpose of the Study:
- To investigate the associations between mismatch negativity (MMN) amplitudes in schizophrenia patients and other neurophysiological and structural markers.
- To compare patients with high MMN amplitudes (Group A) versus low MMN amplitudes (Group B) before treatment.
Main Methods:
- Quantitative EEG (QEEG) was used to assess brain activity.
- Computed tomography (CT) scans were performed to evaluate brain structure.
- Psychopathological ratings were collected.
- Patients were categorized into Group A (higher MMN) and Group B (lower MMN).
Main Results:
- Group A (higher MMN) showed largely preserved QEEG compared to controls, with only increased frontal fast beta activity.
- Group B (lower MMN) exhibited increased slow waves, slow alpha, and fast beta power in QEEG.
- Group B also showed greater ventricular and Sylvian fissure dilation on CT, suggesting more significant structural changes.
Conclusions:
- MMN amplitudes are critically related to other biological markers in schizophrenia.
- Lower MMN is associated with poorer QEEG profiles and greater brain structural abnormalities.
- MMN serves as a valuable biomarker reflecting the psychopathology and cognitive status in schizophrenia.